Market Overview
The Central Nervous System Biomarkers
Market Size is expected to record a CAGR of ~12.8% during the forecast period
2022-2030. The Central Nervous System (CNS) biomarkers support new drug
discovery and development, further helping indecision-making regarding drug
treatment and its effectiveness. Moreover, biomarkers also help in the
understanding of the disease mechanism and improve the quality of patient care.
The major factors driving the CNS biomarkers market include new technological
advancements and their increased use in the diagnosis of neurodegenerative
diseases. Moreover, an increase in R&D for new CNS biomarkers and
successful clinical trials further contribute to the central nervous system
biomarkers market growth.
Competitive Dynamics
The global CNS
biomarkers market players are
Thermo Fisher Scientific (US),
Merck & Co. (US),
AbaStarMDx Inc. (US),
Abiant, Inc. (US),
Avacta Group plc (UK),
Diagenic Asa (Norway),
Banyan Biomarkers (US),
Avid Radiopharmaceuticals Inc. (US), and
Acumen Pharmaceuticals Inc. (US)
Among others.
Segmental Analysis
The global market for CNS biomarkers has
been divided into three categories: type, application, and end user.
·
The market has been divided
into types such as safety biomarker, efficacy
biomarker, validation biomarker, and others.
·
based on application: The global CNS biomarkers market has been divided into three
categories drug discovery and development, personalised medicine, and others.
·
based on end user: The CNS biomarkers market is divided into diagnostic labs,
hospitals & clinics, and research centres.
Market Dynamics
New technology breakthroughs and their
rising application in the diagnosis of neurodegenerative illnesses are two
important reasons driving the CNS biomarkers market. Furthermore, increased
R&D for new CNS biomarkers as well as successful clinical studies
contribute to the growth of the central nervous system biomarkers market.
Identifying new biomarkers will make it easier to look for new diagnostic and
prognostic signs that might be used to track the efficacy of a new medication
or provide a new disease treatment target. High throughput scanning of the
human genome and its encoded proteins, for example, has enabled systematic
analysis of human disease. These technologies are proven to be a more effective
way of discovering the biological foundation of genetically complex
neurological diseases.
Regional Overview
Increasing CNS cancer cases and R&D
spending are expected to boost central nervous system biomarkers market growth
in this region over the forecast period. Furthermore, businesses and research
institutes are continually inventing and developing new technologies and
biomarkers, which is aided by the presence of major competitors in the region
as well as increased R&D spending. As a result of these factors, North
America is likely to dominate the central nervous system biomarkers market for
the foreseeable future.
The central
nervous system biomarkers market insights in Europe is being driven by an
increase in demand for personalized/precision medicine and the increased
prevalence of neurological illnesses in the region. The European regulatory
network is helping to promote personalised treatment for CNS illnesses such
pharmacogenomics, biomarkers, companion diagnostics, and uncommon diseases, as
well as innovative techniques and clinical trial designs.
Due to factors such as a huge consumer
base, high prevalence of CNS illnesses, and improved healthcare infrastructure,
the Asia-Pacific region is expected to be the fastest-growing regional market
over the projection period. Furthermore, enhancing research capacity and
strengthening healthcare infrastructure will aid in the development of novel
CNS biomarkers.
The Middle East, Africa, and Latin America
are included in the rest of the world. These areas are also seeing an increase
in neurological illnesses, which is fueling the market for central nervous
system biomarkers.
About US:
Market Research
Future (MRFR) enable customers to unravel the complexity of various industries
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
Contact us:
Market Research
Future (part of Wantstats Research and Media Private Limited),
99 Hudson
Street,5Th Floor, New York,
New York 10013
